[Embryonic quality in the use of urofolitropin vs recombinant FSH for in vitro fertilization].
There were no differences in both groups as tho the age of the patients; received doses of both types of FSH, nor HMG; but there was as to the amount of captured ovocytes, amount, and quality, embrionary, in special 1+ 2+ in favor of the group that received urofolitropine, specially under 35 years of age. In this study there was better qualy and amount, embrionary, obtained with the use of urofolitropine, as compared with FSH recombinant for in vitro fertilization.
Contreras Bretherton
C
C
Grupo de Reproducción Asistida y Genética, AGN y Asociados, Hospital Angeles del Pedregal México D.F.
David Vargas
R
R
Cedillo
F J
FJ
Vilchez
R
R
Das Neves
D
D
Bernal
M A
MA
Verez Ruíz
J R
JR
Stern Colin y Nunes
J J
JJ
Gutiérrez Nájar
A
A
D000328:Adult; D004622:Embryo, Mammalian / Q000502:physiology*; D005260:Female; D005307:Fertilization in Vitro / Q000187:drug effects / Q000379:methods; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D006801:Humans; D008596:Menotropins / Q000494:pharmacology*; D011247:Pregnancy
D008596:Menotropins; D005640:Follicle Stimulating Hormone
Calidad embrionaria en la utilización de urofolitropina vs FSH recombinante para fertilización in vitro.